139 related articles for article (PubMed ID: 24365642)
1. The microenvironment in lymphomas--dissecting the complex crosstalk between tumor cells and 'by-stander' cells.
Rosenquist R; Davi F; Ghia P
Semin Cancer Biol; 2014 Feb; 24():1-2. PubMed ID: 24365642
[TBL] [Abstract][Full Text] [Related]
2. The challenge of the microenvironment in B-cell lymphomas.
Coupland SE
Histopathology; 2011 Jan; 58(1):69-80. PubMed ID: 21261684
[TBL] [Abstract][Full Text] [Related]
3. The microenvironment in T-cell lymphomas: emerging themes.
Gaulard P; de Leval L
Semin Cancer Biol; 2014 Feb; 24():49-60. PubMed ID: 24316493
[TBL] [Abstract][Full Text] [Related]
4. Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
Baecklund E; Smedby KE; Sutton LA; Askling J; Rosenquist R
Semin Cancer Biol; 2014 Feb; 24():61-70. PubMed ID: 24333759
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
Karube K; Scarfò L; Campo E; Ghia P
Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
[TBL] [Abstract][Full Text] [Related]
6. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
7. Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type.
Thieblemont C; Bertoni F; Copie-Bergman C; Ferreri AJ; Ponzoni M
Semin Cancer Biol; 2014 Feb; 24():33-42. PubMed ID: 24333758
[TBL] [Abstract][Full Text] [Related]
8. The tumor microenvironment in follicular lymphoma.
Yang ZZ; Ansell SM
Clin Adv Hematol Oncol; 2012 Dec; 10(12):810-8. PubMed ID: 23271353
[TBL] [Abstract][Full Text] [Related]
9. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
10. The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.
Amé-Thomas P; Tarte K
Semin Cancer Biol; 2014 Feb; 24():23-32. PubMed ID: 23978491
[TBL] [Abstract][Full Text] [Related]
11. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
12. Shaping of the tumor microenvironment: Stromal cells and vessels.
Blonska M; Agarwal NK; Vega F
Semin Cancer Biol; 2015 Oct; 34():3-13. PubMed ID: 25794825
[TBL] [Abstract][Full Text] [Related]
13. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
14. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
15. Genomic alterations underlying immune privilege in malignant lymphomas.
Mottok A; Steidl C
Curr Opin Hematol; 2015 Jul; 22(4):343-54. PubMed ID: 26049756
[TBL] [Abstract][Full Text] [Related]
16. Small B-cell lymphomas of the lymph nodes and spleen: practical insights to diagnosis and pathogenesis.
Swerdlow SH
Mod Pathol; 1999 Feb; 12(2):125-40. PubMed ID: 10071338
[TBL] [Abstract][Full Text] [Related]
17. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
18. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
Xerri L; Chetaille B; Serriari N; Attias C; Guillaume Y; Arnoulet C; Olive D
Hum Pathol; 2008 Jul; 39(7):1050-8. PubMed ID: 18479731
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy.
Ramsay AD; Rodriguez-Justo M
Br J Haematol; 2013 Jul; 162(1):15-24. PubMed ID: 23617880
[TBL] [Abstract][Full Text] [Related]
20. Immunologic markers in non-Hodgkin's lymphoma.
Freedman AS; Nadler LM
Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]